anti-ADK antibody product blog
Tags: Antibody; ADK; anti-ADK antibody; Monoclonal Antibody;
The ADK adk (Catalog #MBS415003) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s ADK can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Western Blot (WB-Ce).WB: 1:500 analysis of ADK expression in HEK293 whole cell lysate with Anti- ADK. Researchers should empirically determine the suitability of the ADK adk for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The ADK adk product has the following accession number(s) (GI #154350506) (NCBI Accession #ABS72585.1). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the Anti-ADK Antibody with the following immunoassay(s):
Testing Data
Raised In: Purified mouse monoclonal antibody generated using E.coli expressed recombinant protein ADK as immunogen.
Storage Buffer: PBS, pH 7.4 with 0.02% sodium azide. Immunogen: Recombinant protein corresponding to fragment (aa/138-362) ADK. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing ADK are readily searchable from our website. Different antibodies against the same target such as ADK may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.